SCHEMBL19929833

SCHEMBL19929833

COc1ccc(-c2oc3cc(C)cc(C)c3c2-c2cc(C)cc(OC)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ CSNK2A2 P19784 3/20 0.46
▸ CSNK2B P67870 3/20 0.46
▸ CSNK2A1 P68400 3/20 0.46
▸ ADORA3 P0DMS8 2/20 0.44
▸ SLC22A2 O15244 1/20 0.44
▸ SLC22A1 O15245 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.43
▸ CYP1A2 P05177 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CYP1A1 P04798 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ FTO Q9C0B1 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929838 0.87 MAPT (0.51) MAPTALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL19929845 0.84 MAPT (0.41) MAPTALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL19929844 0.83 ALDH1A1 (0.46) MAPTALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL19929825 0.80 MAPT (0.56) MAPTALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL19929840 0.77 L3MBTL1 (0.44) MAPTALDH1A1ADORA3ABCG2CYP1A2
SCHEMBL30022887 0.74 ALDH1A1 (0.50) MAPTALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL19934846 0.73 SLC22A2 (0.46) MAPTALDH1A1ADORA3SLC22A2SLC22A1
SCHEMBL28654875 0.72 KDM4E (0.50) MAPTALDH1A1ADORA3SLC22A2SLC22A1
SCHEMBL30022955 0.72 KDM4E (0.50) MAPTALDH1A1ADORA3SLC22A2SLC22A1
SCHEMBL19934782 0.71 ALDH1A1 (0.51) MAPTALDH1A1ADORA3SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 MAPT 4251/4885ALDH1A1 2161/4885CSNK2A2 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback